```html

Scleral Icterus: What It Is, Why It Happens, and When to Get Help

What is Scleral icterus?

Scleral icterus (also called “jaundice of the whites of the eyes”) is a yellow‑orange discoloration of the sclera – the tough, white outer layer of the eye. The color change occurs when bilirubin, a yellow pigment produced by the breakdown of red blood cells, builds up in the bloodstream (hyperbilirubinemia) and deposits in the connective tissue of the sclera. Because the sclera is thin and poorly pigmented, even modest elevations in serum bilirubin (≈2–3 mg/dL) can produce a noticeable yellow hue, often before the skin becomes visibly jaundiced.

The finding is important in clinical practice because it may be the first visible clue that the liver, gallbladder, or blood‑forming system is not functioning normally. While the sclera itself is not painful, the underlying cause can range from benign to life‑threatening.

Common Causes

Below are the most frequent conditions that can cause scleral icterus. They can be grouped by the primary organ system involved.

• Hepatocellular injury – viral hepatitis (A, B, C, E), alcoholic liver disease, non‑alcoholic fatty liver disease (NAFLD), drug‑induced liver injury, autoimmune hepatitis.
• Biliary obstruction – gallstones, cholangiocarcinoma, pancreatic head cancer, biliary strictures, primary sclerosing cholangitis.
• Hemolysis – hereditary spherocytosis, G6PD deficiency, autoimmune hemolytic anemia, sickle‑cell disease, transfusion reactions.
• Genetic disorders of bilirubin metabolism – Gilbert syndrome, Crigler‑Najjar syndrome.
• Sepsis or severe infection – especially with hepatic involvement (e.g., sepsis‑associated cholestasis).
• Pregnancy‑related cholestasis – intra‑hepatic cholestasis of pregnancy.
• Medications & toxic exposures – acetaminophen overdose, isoniazid, rifampin, antiretrovirals, certain herbal supplements.
• Heart failure – right‑sided congestive heart failure can cause hepatic congestion and impaired bilirubin clearance.
• Pancreatitis – especially when it extends to the common bile duct.
• Neonatal physiologic jaundice – common in newborns but typically resolves within the first week of life.

Associated Symptoms

Because scleral icterus reflects a systemic problem, other signs and symptoms often accompany it. The exact pattern depends on the underlying cause.

• Generalized skin yellowing (jaundice)
• Dark urine (bilirubin excreted in urine)
• Pale, clay‑colored stools (lack of bilirubin reaching the intestine)
• Pruritus (bile salts deposited in skin)
• Abdominal pain or fullness, especially in the right upper quadrant
• Fever and chills (suggesting infection or cholangitis)
• Fatigue, weakness, or loss of appetite
• Weight loss (often seen with malignancy)
• Bruising or easy bleeding (coagulopathy due to liver dysfunction)
• Upper‑right‑sided respiratory or cardiac symptoms if congestive hepatopathy is present

When to See a Doctor

Any new yellowing of the eyes warrants evaluation, but urgent medical attention is required if any of the following are present:

• Rapid progression of yellow discoloration (within 24‑48 hours)
• Accompanying fever > 101 °F (38.3 °C) or chills
• Severe abdominal pain, especially with tenderness in the right upper quadrant
• Confusion, altered mental status, or difficulty waking (possible hepatic encephalopathy)
• Vomiting bile or persistent vomiting
• Dark urine combined with light‑colored stools
• Signs of bleeding (easy bruising, nosebleeds, blood in stools)
• History of recent travel, new medication, or known liver disease.

Even in the absence of red‑flag symptoms, a primary‑care or gastroenterology visit should be arranged promptly (within a few days) to identify the cause.

Diagnosis

Evaluation follows a stepwise approach:

1. Clinical Examination

• Confirm scleral icterus with good lighting; compare both eyes.
• Assess for liver palpability, ascites, edema, and any abdominal tenderness.
• Check for stigmata of chronic liver disease (spider angiomas, palmar erythema, gynecomastia).

2. Laboratory Tests

• Serum bilirubin – total and direct (conjugated) fractions help distinguish hepatocellular vs. obstructive causes.
• Liver enzymes – ALT, AST, alkaline phosphatase, GGT.
• Complete blood count – anemia or leukocytosis.
• Coagulation profile – PT/INR, especially if liver synthesis is impaired.
• Serologies – hepatitis A, B, C; EBV, CMV; autoimmune markers (ANA, ASMA).
• Hemolysis work‑up – haptoglobin, LDH, reticulocyte count, peripheral smear.

3. Imaging Studies

• Abdominal ultrasound – first‑line to assess liver size, gallbladder stones, biliary duct dilation.
• CT or MRI – for detailed evaluation of masses, pancreatic lesions, or complex biliary anatomy.
• MRCP (magnetic resonance cholangiopancreatography) – non‑invasive view of the biliary tree.

4. Specialized Tests

• Endoscopic Retrograde Cholangiopancreatography (ERCP) – both diagnostic and therapeutic for biliary obstruction.
• Liver biopsy – rarely needed but may clarify autoimmune or infiltrative disease.
• Genetic testing – for suspected Gilbert or Crigler‑Najjar syndromes.

All diagnostic steps should be guided by the patient’s history, physical findings, and initial laboratory results.

Treatment Options

Treatment focuses on the underlying cause; the scleral coloration usually improves once bilirubin levels fall.

1. Hepatocellular Injuries

• Viral hepatitis – antiviral therapy (e.g., entecavir, tenofovir for hepatitis B; direct‑acting antivirals for hepatitis C).
• Alcoholic liver disease – complete abstinence, nutritional support, corticosteroids for severe alcoholic hepatitis.
• Drug‑induced injury – immediate cessation of the offending agent; N‑acetylcysteine for acetaminophen toxicity.
• Autoimmune hepatitis – corticosteroids and azathioprine.

2. Biliary Obstruction

• Gallstone removal – laparoscopic cholecystectomy or endoscopic sphincterotomy.
• Malignancy – surgical resection, stenting, chemotherapy, or palliative radiation.
• Strictures – endoscopic dilation or placement of biliary stents.

3. Hemolytic Disorders

• Treat trigger – discontinue oxidant drugs, manage infections.
• Specific therapy – steroids for autoimmune hemolysis, exchange transfusion for severe sickle‑cell crisis, splenectomy for hereditary spherocytosis.

4. Supportive & Home Measures

• Hydration – adequate oral fluid intake helps bilirubin excretion.
• Nutrition – a balanced diet low in saturated fats; avoid alcohol.
• Phototherapy – primarily used in neonates with severe hyperbilirubinemia.
• Pruritus relief – cholestyramine, antihistamines, or rifampin.

5. Monitoring

Patients with chronic liver disease should have periodic liver function tests, imaging, and surveillance for hepatocellular carcinoma per AASLD guidelines.

Prevention Tips

While not all causes are avoidable, many risk factors can be modified.

• Vaccinate against hepatitis A and B.
• Practice safe sex and avoid sharing needles to reduce hepatitis C risk.
• Limit alcohol consumption – stay within recommended limits (≤ 2 drinks/day for men, ≤ 1 drink/day for women).
• Maintain a healthy weight and exercise regularly to lower NAFLD risk.
• Use medications as prescribed; read warnings about hepatotoxicity.
• Stay current on vaccinations for seasonal flu and COVID‑19, which can precipitate liver inflammation.
• For pregnant women, report any itching or yellowing promptly; intra‑hepatic cholestasis of pregnancy can harm the fetus.
• Wear protective equipment when handling chemicals or solvents known to affect the liver.

Emergency Warning Signs

Key Take‑aways

Scleral icterus is a visible sign that bilirubin is building up in the body. While it often points to liver or biliary disease, a thorough evaluation can uncover a wide range of causes, from simple genetic variations to life‑threatening cancers. Early recognition and prompt medical evaluation are essential, especially when accompanied by fever, severe pain, or neurological changes. With appropriate treatment of the underlying condition and lifestyle measures to protect liver health, most patients see resolution of the yellowing and prevent future episodes.

For up‑to‑date guidelines and detailed information, consult reputable sources such as the Mayo Clinic, the CDC, the NIH, the World Health Organization, and the Cleveland Clinic.

```